Prostate cancer detection with magnetic resonance-ultrasound fusion biopsy: The role of systematic and targeted biopsies Academic Article uri icon

Overview

MeSH Major

  • Biopsy, Needle
  • Image-Guided Biopsy
  • Magnetic Resonance Imaging
  • Multimodal Imaging
  • Prostatic Neoplasms
  • Ultrasonography, Interventional

abstract

  • In this prospective trial, MR-ultrasound fusion biopsy allowed for the detection of csCaP, with a direct relationship noted with ROI grade and prostate-specific antigen density. The combination of targeted and systematic biopsy detected more csCaP than either modality alone; systematic biopsies revealed csCaP in 16% of men with no suspicious MRI target. The advantages of this new biopsy method are apparent, but issues of cost, training, and reliability await resolution before its widespread adoption.

publication date

  • March 15, 2016

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC4777653

Digital Object Identifier (DOI)

  • 10.1002/cncr.29874

PubMed ID

  • 26749141

Additional Document Info

start page

  • 884

end page

  • 92

volume

  • 122

number

  • 6